The DOI matches its Crossref record, with a small difference in title or year; 23 of the 23 references it cites were found in a registry or an index.
Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial
Abstract
We wished to determine whether the Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R) is reliable when used as primary outcome measure in a multicenter clinical trial. To establish inter-rater reliability, we randomly assigned 19 primary raters and 11 back-up raters to score nine amyotrophic lateral sclerosis (ALS) patients using the ALSFRS-R. To assess intra-rater reliability and reliability of telephone administration, we randomly assigned consecutive participants of the Clinical Trial of High Dose Coenzyme Q10 in ALS (QALS) to have in-person ALSFRS-R interviews at both screening and baseline visits (n=41 patients) or to have the ALSFRS-R interview by telephone at screening and in person at the baseline visit (n=27). An intraclass correlation coefficient (ICC) of reliability was calculated using a one-way random effects analysis of variance model. In the inter-rater reliability assessment, the primary raters performed 54 ratings on nine patients with ICC=0.93 (95% CI 0.84-0.98). For back-up raters, 32 ratings on nine patients resulted in ICC=0.93 (95% CI 0.82-0.98). The intra-rater reliability for in-person interviews was ICC = 0.95 (95% CI 0.92-0.98). The reliability of telephone administration compared to in-person interviews was ICC=0.97 (95% CI 0.93-0.98). We conclude that the ALSFRS-R shows excellent inter- and intra-rater reliability, and reliability of telephone administration when used as primary outcome measure in a multicenter ALS trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The administration of the ALSFRS-R by trained non-clinicians has been demonstrated to have exemplary inter-rater, intra-rater, and telephone-administered reliability (21).”
From Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort (2018) · cites this paper as [21]
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
The Design and Analysis of Clinical Experiments
Fleiss, J. L. (1999) · Wiley eBooks · doi:10.1002/9781118032923 · Cited by 4,819
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,239
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V., Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,303
A controlled trial of recombinant methionyl human BDNF in ALS
The BDNF Study Group (Phase III) (1999) · Neurology · doi:10.1212/wnl.52.7.1427 · Cited by 453
ALS CNTF Treatment Study Group (1996) · Neurology · doi:10.1212/wnl.46.5.1244 · Cited by 405
Effect of recombinant human insulin-like growth factor-I on progression of ALS
Lai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., Murphy, M. F., Natter, H. M., Norris, F. H., Rudnicki, S. A., et al. (1997) · Neurology · doi:10.1212/wnl.49.6.1621 · Cited by 361
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
Borasio, G. D., Robberecht, W., Leigh, P. N., Emile, J., Guiloff, R. J., Jerusalem, F., Silani, V., Vos, P. E., Wokke, J. H. J., Dobbins, T., et al. (1998) · Neurology · doi:10.1212/wnl.51.2.583 · Cited by 339
A clinical trial of creatine in ALS
Shefner, J. M., Cudkowicz, M., Schoenfeld, D., Conrad, T. M., Taft, J., Chilton, M., Urbinelli, L., Qureshi, M., Zhang, H., Pestronk, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142992.81995.f0 · Cited by 293
Self-citation
Research works printed but not linked: 3
- Moore D. H., 2003, Amyotroph Lateral Scler Other Motor Neuron Disord, 4, 42
- Traynor B. J., 2003, Amyotroph Lateral Scler Other Motor Neuron Disord, 4, 42
- Levy G., Neurology
Cited by
Sorted by citations
Abrahao, A., Meng, Y., Llinas, M., Huang, Y., Hamani, C., Mainprize, T., Aubert, I., Heyn, C., Black, S. E., Hynynen, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12426-9 · Cited by 476
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
Kaufmann, P., Thompson, J. L. P., Levy, G., Buchsbaum, R., Shefner, J. M., Krivickas, L. S., Katz, J., Rollins, Y. D., Barohn, R. J., Jackson, C. E., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21743 · Cited by 236
Self-citationStem cell treatment in Amyotrophic Lateral Sclerosis
Mazzini, L., Mareschi, K., Ferrero, I., Vassallo, E., Oliveri, G., Nasuelli, N. A., Oggioni, G. D., Testa, L., & Fagioli, F. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.05.016 · Cited by 227
Huggins, J. E., Wren, P. A., & Gruis, K. L. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.572978 · Cited by 215
Nandedkar, S. D., Barkhaus, P. E., & Stålberg, E. (2010) · Muscle & Nerve · doi:10.1002/mus.21824 · Cited by 206
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
Cudkowicz, M., Bozik, M. E., Ingersoll, E. W., Miller, R. G., Mitsumoto, H., Shefner, J. M., Moore, D. H., Schoenfeld, D., Mather, J. L., Archibald, D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2579 · Cited by 178
Self-citationFranchignoni, F. P., Mora, G., Giordano, A., Volanti, P., & Chiò, A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304701 · Cited by 166
Caligari, M., Godi, M., Guglielmetti, S., Franchignoni, F. P., & Nardone, A. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.803576 · Cited by 162
Clinical Measures of Bulbar Dysfunction in ALS
Yunusova, Y., Plowman, E. K., Green, J. R., Barnett, C., & Bede, P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00106 · Cited by 147
Bede, P., Bokde, A. L. W., Elamin, M., Byrne, S., McLaughlin, R. L., Jordan, N., Hampel, H. J., Gallagher, L. B., Lynch, C. M., Fagan, A. J., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302674 · Cited by 141
Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?
Keizman, D., Ish‐Shalom, M., Berliner, S. A., Maimon, N., Vered, Y., Artamonov, I., Tsehori, J., Nefussy, B., & Drory, V. E. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.06.002 · Cited by 133
Beghi, E., Chiò, A., Couratier, P., Esteban‐Pérez, J., Hardiman, O. M., Logroscino, G., Millul, A., Mitchell, D. J., Preux, P., Pupillo, E., et al. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.502940 · Cited by 132
Neuwirth, C., Nandedkar, S. D., Stålberg, E., & Weber, M. (2010) · Muscle & Nerve · doi:10.1002/mus.21707 · Cited by 121
Emerging targets and treatments in amyotrophic lateral sclerosis
Zinman, L. H., & Cudkowicz, M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70024-2 · Cited by 111
Watanabe, H., Atsuta, N., Nakamura, R., Hirakawa, A., Watanabe, H., Ito, M., Senda, J., Katsuno, M., Izumi, Y., Morita, M., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.990036 · Cited by 95
Speech Movement Measures as Markers of Bulbar Disease in Amyotrophic Lateral Sclerosis
Shellikeri, S., Green, J. R., Kulkarni, M., Rong, P., Martino, R., Zinman, L. H., & Yunusova, Y. (2016) · Journal of Speech Language and Hearing Research · doi:10.1044/2016_jslhr-s-15-0238 · Cited by 93
Maier, A., Holm, T., Wicks, P. J., Steinfurth, L., Linke, P., Münch, C., Meyer, R., & Meyer, T. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.633268 · Cited by 87
Allison, K. M., Yunusova, Y., Campbell, T. F., Wang, J., Berry, J. D., & Green, J. R. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1303515 · Cited by 87
Neuwirth, C., Barkhaus, P. E., Burkhardt, C., Castro, J., Czell, D., de Carvalho, M. A., Nandedkar, S. D., Stålberg, E., & Weber, M. (2016) · Clinical Neurophysiology · doi:10.1016/j.clinph.2016.11.026 · Cited by 84
Kim, H. Y., Kim, H., Oh, K., Oh, S., Koh, S., Baik, W., Noh, M., Kim, K. S., & Kim, S. H. (2014) · Stem Cells · doi:10.1002/stem.1770 · Cited by 83
Stipancic, K. L., Yunusova, Y., Berry, J. D., & Green, J. R. (2018) · Journal of Speech Language and Hearing Research · doi:10.1044/2018_jslhr-s-17-0366 · Cited by 83
Fournier, C. N., Bedlack, R., Quinn, C. C., Russell, J., Beckwith, D., Kaminski, K. H., Tyor, W. R., Hertzberg, V., James, V., Polak, M. A., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4490 · Cited by 82
Schuster, C., Kasper, E., Machts, J., Bittner, D., Kaufmann, J., Benecke, R., Teipel, S. J., Vielhaber, S., & Prudlo, J. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7083-z · Cited by 82
Measuring function in advanced ALS: validation of ALSFRS‐EX extension items
Wicks, P. J., Massagli, M. P., Wolf, C., & Heywood, J. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02434.x · Cited by 82
Outcome measures in amyotrophic lateral sclerosis clinical trials
Paganoni, S., Cudkowicz, M., & Berry, J. D. (2014) · Clinical Investigation · doi:10.4155/cli.14.52 · Cited by 70
Bakker, L. A., Schröder, C. D., Tan, H. H. G., Vugts, S. M. A. G., van Eijk, R. P. A., van Es, M. A., Visser‐Meily, J. M. A., & van den Berg, L. H. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321138 · Cited by 70
Oskoui, M., & Kaufmann, P. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.007 · Cited by 69
Self-citationFranchignoni, F. P., Mandrioli, J., Giordano, A., Ferro, S., & ERRALS Group (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1026829 · Cited by 68
Patterns of Spontaneous Brain Activity in Amyotrophic Lateral Sclerosis: A Resting-State fMRI Study
Luo, C., Chen, Q., Huang, R., Chen, X., Chen, K., Huang, X., Tang, H., Gong, Q., & Shang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045470 · Cited by 68
Neuwirth, C., Braun, N., Claeys, K. G., Bucelli, R. C., Fournier, C. N., Bromberg, M. B., Petri, S., Goedee, H. S., Lenglet, T., Leppanen, R. E., et al. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.04.614 · Cited by 66
Guedes, K., Pereira, C., Pavan, K., & Valério, B. C. O. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000100010 · Cited by 64
Clinical Outcome Measures in Spinal Muscular Atrophy
Montes, J., Gordon, A. M., Pandya, S., Vivo, D. C. D., & Kaufmann, P. (2009) · Journal of Child Neurology · doi:10.1177/0883073809332702 · Cited by 62
Self-citationClinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis
Rutkove, S. B. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0331-9 · Cited by 59
Andrews, J. A., Berry, J. D., Baloh, R. H., Carberry, N., Cudkowicz, M. E., Dedi, B., Glass, J., Maragakis, N. J., Miller, T. M., Paganoni, S., et al. (2020) · Muscle & Nerve · doi:10.1002/mus.26989 · Cited by 57
Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy
ERRALS Group, Mandrioli, J., Biguzzi, S., Guidi, C., Sette, E., Terlizzi, E., Ravasio, A., Casmiro, M., Salvi, F., Liguori, R., et al. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2343-6 · Cited by 58
Bakker, L. A., Schröder, C. D., van Es, M. A., Westers, P., Visser‐Meily, J. M. A., & van den Berg, L. H. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8538-4 · Cited by 58
Capozzo, R., Zoccolella, S., Musio, M., Barone, R., Accogli, M., & Logroscino, G. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1773502 · Cited by 57
Amyotrophic lateral sclerosis patients' self‐reported satisfaction with assistive technology
Gruis, K. L., Wren, P. A., & Huggins, J. E. (2011) · Muscle & Nerve · doi:10.1002/mus.21951 · Cited by 55
Economic burden of amyotrophic lateral sclerosis: A Canadian study of out-of-pocket expenses
Gladman, M., Dharamshi, C., & Zinman, L. H. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.932382 · Cited by 54
Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients
Nakamura, R., Atsuta, N., Watanabe, H., Hirakawa, A., Watanabe, H., Ito, M., Senda, J., Katsuno, M., Tanaka, F., Izumi, Y., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306020 · Cited by 52
Abdulla, S., Vielhaber, S., Körner, S., Machts, J., Heinze, H., Dengler, R., & Petri, S. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6955-6 · Cited by 49
Kovalchuk, M. O., Heuberger, J. A. A. C., Sleutjes, B. T. H. M., Ziagkos, D., van den Berg, L. H., Ferguson, T. A., Franssen, H., & Groeneveld, G. J. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1096 · Cited by 48
Maier, A., Boentert, M., Reilich, P., Witzel, S., Petri, S., Großkreutz, J., Metelmann, M., Lingor, P., Cordts, I., Dorst, J., et al. (2022) · Neurological Research and Practice · doi:10.1186/s42466-022-00224-6 · Cited by 46
The Clinical and Radiological Spectrum of Hippocampal Pathology in Amyotrophic Lateral Sclerosis
Christidi, F., Karavasilis, E., Velonakis, G., Ferentinos, P. P., Rentzos, M., Kelekis, N., Evdokimidis, I., & Bede, P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00523 · Cited by 46
Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort
Walt, G. S., Burris, H. M., Brady, C. B., Spencer, K. R., Alvarez, V. E., Huber, B. R., Guilderson, L., Abdul Rauf, N., Collins, D., Singh, T., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly092 · Cited by 45
A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression ofTTN
Watanabe, H., Atsuta, N., Hirakawa, A., Nakamura, R., Nakatochi, M., Ishigaki, S., Iida, A., Ikegawa, S., Kubo, M., Yokoi, D., et al. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311541 · Cited by 43
Comparison of outcome measures from a trial of Mycophenolate mofetil in myasthenia gravis
Wolfe, G. I., Barohn, R. J., Sanders, D. B., & McDermott, M. P. (2008) · Muscle & Nerve · doi:10.1002/mus.21142 · Cited by 39
Bacci, E. D., Staniewska, D., Coyne, K. S., Boyer, S., White, L. A., Zach, N., Cedarbaum, J. M., & The Pooled Resource Open-Access ALS Clinical Trials Consortium (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1095930 · Cited by 39
Green, J. R., Allison, K. M., Cordella, C., Richburg, B. D., Pattee, G. L., Berry, J. D., Macklin, E. A., Pioro, E. P., & Smith, R. A. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13745 · Cited by 39
A plug-and-play brain-computer interface to operate commercial assistive technology
Thompson, D. E., Gruis, K. L., & Huggins, J. E. (2013) · Disability and Rehabilitation Assistive Technology · doi:10.3109/17483107.2013.785036 · Cited by 37
Macchi, Z. A., Wang, Y., Moore, D. H., Katz, J., Saperstein, D., Walk, D., Simpson, E. P., Genge, A. L., Bertorini, T. E., Fernandes, J. A., et al. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1026826 · Cited by 36
Qualitative measures that assess functional disability and quality of life in ALS
Hartmaier, S. L., Rhodes, T., Cook, S. F., Schlusser, C. L., Chen, C., Han, S., Zach, N., Murthy, V., & Davé, S. (2022) · Health and Quality of Life Outcomes · doi:10.1186/s12955-022-01919-9 · Cited by 40
JaCALS, Yokoi, D., Atsuta, N., Watanabe, H., Nakamura, R., Hirakawa, A., Ito, M., Watanabe, H., Katsuno, M., Izumi, Y., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8109-0 · Cited by 37
Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale
Mitsumoto, H., Chiuzan, C. C., Gilmore, M., Zhang, Y., Simmons, Z., Paganoni, S., Kisanuki, Y. Y., Zinman, L. H., Jawdat, O., Sorenson, E. J., et al. (2019) · Muscle & Nerve · doi:10.1002/mus.26765 · Cited by 36
Self-citationElektive Termination der Beatmungstherapie bei der amyotrophen Lateralsklerose
Meyer, T., Dullinger, J. S., Münch, C., Keil, J., Hempel, E., Rosseau, S., Borisow, N., & Linke, P. (2008) · Der Nervenarzt · doi:10.1007/s00115-008-2439-9 · Cited by 36
Meyer, T., Spittel, S., Grehl, T., Weyen, U., Steinbach, R., Kettemann, D., Petri, S., Weydt, P., Günther, R., Baum, P., et al. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2104649 · Cited by 35
Wong, C., Dakin, R. S., Williamson, J., Newton, J. L., Steven, M., Colville, S., Stavrou, M., Gregory, J. M., Elliott, E., Mehta, A. R., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-064173 · Cited by 39
Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials
Govindarajan, R., Berry, J. D., Paganoni, S., Pulley, M., & Simmons, Z. (2020) · Muscle & Nerve · doi:10.1002/mus.26921 · Cited by 31
Montes, J., Eichinger, K. J., Pasternak, A. E., Kanner, C. H., & Krosschell, K. J. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02165-w · Cited by 28
Self-citationGrimaldi, S., Duprat, L., Grapperon, A., Verschueren, A., Delmont, É., & Attarian, S. (2017) · Muscle & Nerve · doi:10.1002/mus.25595 · Cited by 28
Ladha, S., Chibnik, L., Quintana, M., Wang, J., Macklin, E., Saville, B., Detry, M., Vestrucci, M., Paulon, G., McGlothlin, A., et al. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00173-5 · Cited by 26
Fournier, C. N., James, V., & Glass, J. D. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2153607 · Cited by 26
Outcome measures for early phase clinical trials
Gordon, P. H., Cheng, B., Montes, J., Doorish, C., Albert, S. M., & Mitsumoto, H. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701547958 · Cited by 25
Self-citationZeissler, M., Li, V., Parmar, M., & Carroll, C. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191856 · Cited by 24
Multidisciplinary ALS clinics in the USA: A comparison of those who attend and those who do not
Stephens, H., Felgoise, S. H., Young, J., & Simmons, Z. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.994530 · Cited by 24
A pilot study of neuromuscular ultrasound as a biomarker for amyotrophic lateral sclerosis
Pathak, S., Caress, J. B., Wosiski‐Kuhn, M., Milligan, C., Williams, D., & Cartwright, M. S. (2018) · Muscle & Nerve · doi:10.1002/mus.26360 · Cited by 23
Wills, A.-M. A., Garry, J., Hubbard, J. L., Mezoian, T., Breen, C. T., Ortiz-Miller, C., Nalipinski, P., Sullivan, S. L., Berry, J. D., Cudkowicz, M., et al. (2019) · BMC Neurology · doi:10.1186/s12883-019-1330-6 · Cited by 22
The future of ALS diagnosis and staging: where do we go from here?
Genge, A. L., & Chiò, A. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2150555 · Cited by 21
Designing Clinical Trials in Amyotrophic Lateral Sclerosis
Shefner, J. M. (2008) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2008.02.002 · Cited by 21
Enhancing clinical trials in neurodegenerative disorders
Gladman, M., Cudkowicz, M., & Zinman, L. H. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a309d · Cited by 20
Seeking a measure of clinically meaningful change in ALS
McElhiney, M. C., Rabkin, J. G., Goetz, R. R., Katz, J., Miller, R. G., Forshew, D. A., David, W., Cudkowicz, M., Glass, J. D., Appel, S. H., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.942668 · Cited by 20
Self-citationHamidou, B., Marin, B., Lautrette, G., Nicol, M., Camu, W., Corcia, P., Arné‐Bes, M., Tranchant, C., Clavelou, P., Hannequin, D., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1353098 · Cited by 20
Neuropathological profile of long‐duration amyotrophic lateral sclerosis in military Veterans
Spencer, K. R., Foster, Z. W., Rauf, N. A., Guilderson, L., Collins, D., Averill, J. G., Walker, S. E., Robey, I., Cherry, J. D., Alvarez, V. E., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12876 · Cited by 20
Verdiperstat in Amyotrophic Lateral Sclerosis
Hayden, D., Lai, P.-Y., Donahue, R. A., Chen, H.-W., Wang, J., Mathai, N. M., Lopes, G., McCaffrey, A., Scalia, J., Luppino, S. D., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2024.5249 · Cited by 18
Al‐Chalabi, A., Shaw, P. J., Young, C. A., Morrison, K. E., Murphy, C., Thornhill, M., Kelly, J., Steen, I. N., & Leigh, P. N. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-111 · Cited by 18
Atassi, N., Schoenfeld, D., & Cudkowicz, M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139032445.025 · Cited by 17
Identification of Personal Factors in Motor Neurone Disease: A Pilot Study
Ng, L., & Khan, F. (2011) · Rehabilitation Research and Practice · doi:10.1155/2011/871237 · Cited by 16
Erb, M. K., Calcagno, N., Brown, R. Z., Burke, K. M., Scheier, Z. A., Iyer, A. S., Clark, A., Higgins, M., Keegan, M., Gupta, A. S., et al. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2322549 · Cited by 15
Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R
Jackson, C. E., de Carvalho, M. A., Genge, A. L., Heiman-Patterson, T. D., Shefner, J. M., Wei, J., & Wolff, A. A. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1497658 · Cited by 15
Amyotrophic Lateral Sclerosis in Korea: Clinical Characteristics and Prognostic Factors
백원기, 박아람, Kim, H., & Kim, S. H. (2011) · Journal of the Korean Neurological Association · Cited by 13
Ng, L., & Khan, F. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2011.606345 · Cited by 12
James, N., Power, E., Hogden, A., & Vucic, S. (2018) · Disability and Rehabilitation Assistive Technology · doi:10.1080/17483107.2018.1499139 · Cited by 12
Haji, S., Fujita, K., Oki, R., Osaki, Y., Miyamoto, R., Morino, H., Nagano, S., Atsuta, N., Kanazawa, Y., Matsumoto, Y., et al. (2022) · JMIR Research Protocols · doi:10.2196/42032 · Cited by 11
Jin, J., Hu, F., Zhang, Q., Chen, Q. Y., Li, H., Qin, X., Jia, R., Li, K., Dang, Y., & Dang, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-56665-8 · Cited by 11
Non-self-sufficiency as a primary outcome measure in ALS trials
Marin, B., Bianchi, E., Pupillo, E., Lunetta, C., Tremolizzo, L., Logroscino, G., Chiò, A., Preux, P., & Beghi, E. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1074704 · Cited by 11
Validation of the Italian version of self-administered ALSFRS-R scale
Manera, U., Cabras, S., Daviddi, M., Vasta, R., Torrieri, M. C., Palumbo, F., Bombaci, A., Grassano, M., Solero, L., Peotta, L., et al. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1813307 · Cited by 11
Iranian clinical practice guideline for amyotrophic lateral sclerosis
Boostani, R., Olfati, N., Shamshiri, H., Salimi, Z., Fatehi, F., Hedjazi, S. A., Fakharian, A., Ghasemi, M., Okhovat, A. A., Basiri, K., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1154579 · Cited by 12
Plewa, J., Surampalli, A., Wencel, M., Milad, M., Donkervoort, S. C., Caiozzo, V. J., Goyal, N., Mozaffar, T., & Kimonis, V. E. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2018.06.007 · Cited by 10
Chinese validation of the Rasch‐Built Overall Amyotrophic Lateral Sclerosis Disability Scale
Sun, C., Fournier, C. N., Ye, S., Zhang, N., Ma, Y., & Fan, D. (2021) · European Journal of Neurology · doi:10.1111/ene.14811 · Cited by 10
Clinical Trials in Progressive Neurological Diseases
Bedlack, R., & Cudkowicz, M. (2009) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000209493 · Cited by 10
Accurate ALSFRS-R scores can be generated from retrospective review of clinic notes
Lechtzin, N., Maragakis, N. J., Kimball, R., Busse, A. M., Hoffman, V., & Clawson, L. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802502993 · Cited by 10
Commentary: Measuring what matters: the case for patient generated PROMS
Wicks, P. J. (2015) · BMJ · doi:10.1136/bmj.h54 · Cited by 10
Yamamoto, M., Tanaka, F., Tatsumi, H., & Sobue, G. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.11.1845 · Cited by 9
Steinfurth, L., Grehl, T., Weyen, U., Kettemann, D., Steinbach, R., Rödiger, A., Großkreutz, J., Petri, S., Boentert, M., Weydt, P., et al. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2025.2468404 · Cited by 8
Newton, J. L., Jayaprakash, K., Glasmacher, S. A., McEleney, A., Bethell, A., Fraser, E., Hatrick, J., Haagenrud, H., Stott, G., Dakin, R. S., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116991 · Cited by 8
Neuropsychological sequelae in motor neurone disease: outcomes of a peer support programme
Ng, L., Talman, P. S., & Khan, F. (2011) · International Journal of Therapy and Rehabilitation · doi:10.12968/ijtr.2011.18.8.429 · Cited by 7
Patient/carer perceptions of disability in motor neurone disease and carer coping
Ng, L., Kee, K., Amatya, B., & Khan, F. (2011) · International Journal of Therapy and Rehabilitation · doi:10.12968/ijtr.2011.18.10.568 · Cited by 7
Estimating the minimum important difference in the ALSFRS-R-instrument in people living with MND
Boddy, S. L., Simpson, R. M., Walters, S. J., Bamford, H., Walsh, T., McDermott, C. J., PROSEC3 STUDY GROUP, Christopher, M., Chhetri, S. K., Turner, M. R., et al. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2447916 · Cited by 6
A Review of Clinical Trial Designs in Amyotrophic Lateral Sclerosis
Moore, D. H., Katz, J., & Miller, R. G. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.70 · Cited by 6
Montes, J., Bendotti, C., Tortarolo, M., Cheroni, C., Hallak, H., Speiser, Z., Goren, S., Blaugrund, E., & Gordon, P. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00019-9 · Cited by 6
Self-citation
Metadata
- Authors
- Kaufmann, P., Levy, G., Montes, J., Buchsbaum, R., Barsdorf, A. I., Battista, V., Arbing, R., Gordon, P. H., Mitsumoto, H., Levin, B., Thompson, J. L. P., Kaufmann, P., Levy, G., Montes, J., Buchsbaum, R., Barsdorf, A. I., Battista, V., Arbing, R., Gordon, P. H., Mitsumoto, H., Levin, B., & Thompson, J. L. P.
- Venue
- Amyotrophic Lateral Sclerosis
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 8
- Issue
- 1
- Pages
- 42-46
- ISSN
- 1471-180X (ISSN-L)
- 1748-2968
- OpenAlex
- W2022387525
- Cited by
- 145
- References
- 23
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 13 · 2021: 2 · 2020: 10 · 2019: 7 · 2018: 13 · 2017: 5 · 2016: 4 · 2015: 9 · 2014: 7 · 2013: 8 · 2012: 7
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Amyotrophic Lateral Sclerosis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01 NS48555, R01 NS 48125, R01NS048125, R01NS048555)
- National Center for Research Resources (M01 RR00109, M01RR001066, M01RR000109, K12RR017648, M01-RR01066)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Keywords
- ALSFRS-R, functional rating scale, inter-rater reliability, intra-rater reliability, telephone administration, outcome measure reliability
- MeSH terms
- Activities of Daily Living, Amyotrophic Lateral Sclerosis, Coenzymes, Double-Blind Method, Humans, Retrospective Studies, Severity of Illness Index, Telephone, Ubiquinone, Vitamins, Reproducibility of Results, Caregivers, Sickness Impact Profile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review